Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Alliance Pharma Temettü

Temettü kriter kontrolleri 0/6

Alliance Pharma does not currently pay a dividend.

Anahtar bilgiler

0%

Temettü verimi

0%

Ödeme oranı

Sektör ortalama getirisi2.3%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettüUK£0.0178
Hisse başına kazanç-UK£0.062
Temettü verim tahmini0%

Son temettü güncellemeleri

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if APH's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if APH's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Alliance Pharma Piyasaya Karşı Temettü Getirisi
APH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (APH)0%
Pazarın Alt %25'i (GB)2.1%
Pazarın En İyi %25'i (GB)5.5%
Sektör Ortalaması (Pharmaceuticals)2.3%
Analist tahmini (APH) (3 yıla kadar)0%

Önemli Temettü: Unable to evaluate APH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate APH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: APH is not paying a notable dividend for the UK market.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as APH has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin